文献速递主动脉疾病

EVAR与开放手术治疗IgG4相关及非相关炎性腹主动脉瘤的临床结局

Clinical Outcomes After Endovascular Repair and Open Surgery to Treat Immunoglobulin G4-Related and Nonrelated Inflammatory Abdominal Aortic Aneurysms.
PubMed 文献 · J Endovasc Ther · 2017-09-21

本研究比较了EVAR与开放手术治疗炎性腹主动脉瘤的随访结果,重点分析IgG4相关疾病的影响。40例IAAA患者中,21例为IgG4+(8例EVAR,13例OS),19例为IgG4-(9例EVAR,10例OS)。EVAR治疗的IgG4+患者术后IgG4升高、PAF进展、症状持续的风险更高,且IgG4变化率与PAF和囊径变化率正相关。

要点

  • EVAR治疗的IgG4+ IAAA患者术后症状持续和PAF进展风险更高。
  • IgG4+患者EVAR术后IgG4升高与PAF及囊径增大同步恶化。
  • IgG4+ IAAA患者EVAR术后需频繁监测血清IgG4。

核心结论

  • EVAR治疗的IgG4+ IAAA患者症状持续、PAF进展、囊径增大和IgG4升高的风险更高,开放手术可能更利于完全康复。

研究设计与样本

  • 回顾性比较研究,2005年1月至2015年12月共257例AAA患者,其中40例IAAA(PAF>2mm),21例IgG4+(EVAR 8例,OS 13例),19例IgG4-(EVAR 9例,OS 10例)。

主要发现

  • 与OS IgG4+组相比,EVAR IgG4+组术后IgG4升高更常见(5/8;p=0.006),PAF进展更常见(5/8;p=0.027),术后血清IgG4中位数更高(141 mg/dL;p=0.034),术后PAF中位数更厚(5.1 mm;p=0.016),持续临床症状更常见(p=0.006)。
  • 与EVAR IgG4-患者相比,EVAR IgG4+患者术后PAF显著更厚(p=0.024),术后囊径增加中位数更大(+13.1 mm;p=0.030)。
  • IgG4变化率与PAF变化率显著正相关(R=0.555,p=0.03),与囊径变化率显著正相关(R=0.902,p=0.003)。

临床怎么用

  • 对于IgG4+ IAAA患者,开放手术可能应优先考虑以促进完全康复。
  • EVAR术后应频繁监测血清IgG4以发现并发症。

局限性

  • 样本量较小,为初步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the follow-up results of endovascular aneurysm repair (EVAR) vs open surgery (OS) for inflammatory abdominal aortic aneurysms (IAAAs) with regard to immunoglobulin G4-related diseases (IgG4-RD), which are fibrous inflammatory conditions characterized by elevated serum IgG4 concentrations and numerous infiltrations of IgG4+ plasmacytes. METHODS: Between January 2005 and December 2015, 91 patients were treated with EVAR (begun in 2008) and 166 patients underwent OS for AAA. Forty of these 257 patients had IAAAs identified by a >2-mm thickness of periaortic fibrosis (PAF). Of these 40, 21 had pathologically confirmed IgG4-RD and/or serum IgG4 concentrations ≥135 mg/dL (classified IgG4+); 8 (mean age 76 years; 8 men) were treated with EVAR and 13 (mean age 71 years; 11 men) underwent OS. Of the 19 IgG4- patients with IAAA, 9 (mean age 71 years; 8 men) had EVAR and 10 (mean age 75 years; 9 men) had OS. The 4 subgroups were compared in terms of symptoms, complications, inflammation markers, PAF, and aneurysm diameter using the latest midterm follow-up data (12-24 months). RESULTS: Preoperative aneurysm diameter, PAF, gender, median age, symptoms, and median follow-up period were similar in all groups. Preoperative serum IgG4 was equal in EVAR and OS IgG4+ groups. Compared with the OS IgG4+ group, EVAR IgG4+ patients more frequently had postoperative IgG4 increase (5/8; p=0.006) and PAF progression (5/8; p=0.027), higher postoperative serum IgG4 levels (median 141 mg/dL; p=0.034), a thicker postoperative PAF (median 5.1 mm; p=0.016), and persistent clinical symptoms (p=0.006). Compared with EVAR IgG4- patients, the EVAR IgG4+ patients showed significantly thicker postoperative PAF (p=0.024) and larger increases in postoperative sac diameter (median +13.1 mm; p=0.030). Postoperative PAF and sac diameter frequently and synchronously became worse in the EVAR IgG4+ subgroup with increased IgG4 during follow-up. The rate of change in IgG4 significantly positively correlated with the rates of change in PAF (R=0.555, p=0.03) and sac diameter (R=0.902, p=0.003). CONCLUSION: Though sample sizes were rather small, this pilot study suggested that EVAR-treated IgG4+ IAAA patients have a higher risk of persistent symptoms and increases in PAF, sac diameter, and IgG4 levels. Therefore, OS should be preferred for complete recovery. Frequent monitoring of the postoperative serum IgG4 is necessary following EVAR in IgG4+ patients to detect these complications.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Kasashima S, Kasashima F, Kawashima A, et al. Clinical Outcomes After Endovascular Repair and Open Surgery to Treat Immunoglobulin G4-Related and Nonrelated Inflammatory Abdominal Aortic Aneurysms. J Endovasc Ther. 2017. PMID: 28934889. doi:10.1177/1526602817732316

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。